Cal-Maine Foods (CALM): the egg king, quality and discount
2026-06-22 · By Lubin Danilo, founder of Lubin Investment
Cal-Maine Foods (CALM) is the largest table egg producer in the United States, with roughly 20% national market share. Its current FCF is exceptionally high due to abnormal egg prices since the 2022-2024 avian flu crisis. The price-to-FCF ratio of 5.1x looks very low but partly reflects non-recurring profits tied to the poultry health crisis.
Cal-Maine Foods: the US egg market leader
Cal-Maine Foods (CALM) was founded in 1957 in Mississippi. It is by far the largest producer and distributor of table eggs in the United States, with approximately 50 million laying hens and production capacity representing nearly 20% of national output. The company markets conventional, free-range, organic and enriched eggs under proprietary and private-label brands.
Key financial data
| Indicator | Value |
|---|---|
| Current price | $75.97 |
| FCF per share | $14.90 |
| Price-to-FCF ratio | 5.1x |
| Buy target | $184.34 |
| Gap vs target | +142.6% |
| Sector | Farm Products |
High FCF: opportunity or temporary mirage?
The 2022-2024 avian flu decimated millions of laying hens in the United States, creating an unprecedented egg shortage and pushing prices to historic highs. Cal-Maine, like the entire sector, saw its FCF surge. The FCF per share of $14.90 is probably 2 to 3 times higher than what normalized FCF would be if prices returned to historical levels (2015-2021). Our screener captures this reality and our $184.34 target reflects a valuation based on current data. Investors should keep in mind that this FCF may normalize.
Fundamental quality outside the cycle: still solid
Even removing the extraordinary price effect, CALM remains a structurally quality company. Its leadership position with 20% market share gives it unique negotiating power with retailers. Its balance sheet is solid with little debt. Its ability to navigate cycles relies on deep vertical integration (breeding, farming, packaging, distribution). The company also pays a variable dividend indexed to earnings.
Risks to monitor
- Egg price normalization if poultry production recovers: likely 50-70% FCF reduction
- New avian flu outbreaks: inverse risk (price spike) but production shock
- Regulatory pressure on cage farming (cage-free laws in multiple states)
- Customer concentration: dependence on large retail chains (Walmart, Kroger)
- Volatility in corn and soy costs (feed = main cost driver)
FAQ
Why does CALM have such a low price-to-FCF ratio?
The 5.1x price-to-FCF ratio is artificially low because current FCF is inflated by abnormally high egg prices following the 2022-2024 avian flu. If egg prices normalize, FCF will fall and the real price-to-FCF ratio will be higher.
Is the $184.34 target reliable?
It is calculated on current FCF data (exceptional period). If FCF normalizes to $5-7 per share, the calculated target would be $35-49. Our target should therefore be used cautiously in this context: it reflects available data, not a future projection.
Does Cal-Maine pay a dividend?
Yes, CALM pays a variable dividend: it is calculated as one-third of quarterly net income. During high-profit periods (2022-2024), the dividend was exceptional. In normal times, it is more modest. This mechanism aligns shareholders with the company's actual performance.
Is CALM the only publicly traded egg producer in the US?
CALM is the only major publicly traded egg producer in the United States. Other large producers (Rose Acre Farms, Versova) are private. This unique position gives it particular attention during avian flu crises.
Is the cage-free mandate a major risk for CALM?
It is a transition risk, not an elimination risk. Several states (California, Colorado, Massachusetts) impose cage-free standards. CALM has been investing in this transition for several years, but conversion costs are substantial and may temporarily weigh on margins.
Voir l'analyse CALM sur Lubin Investment
About the author
Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I have analyzed stocks through their fundamentals for several years and invest my own money with this method. I codified it into a tool that judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).